Last updated: February 23, 2026
What is the scope of patent WO2006050244?
Patent WO2006050244, filed under the World Intellectual Property Organization (WIPO), pertains to a pharmaceutical invention. The document covers a specific chemical entity, method of manufacturing, and therapeutic use. The patent claims focus on a novel class of compounds with potential applications in treating specific diseases.
The scope encompasses:
- Chemical compounds: A class of compounds characterized by specific structural features. The patent discloses a general formula with defined substituents.
- Methods of synthesis: Protocols to manufacture the compounds, including reaction schemes, reagents, and conditions.
- Therapeutic applications: The use of claimed compounds in treating particular conditions, most notably neurodegenerative diseases or cancers.
The scope is broad in the chemical claims but explicitly limited to compounds fitting the disclosed structural formulas. The claims extend to derivatives, salts, and prodrugs.
What are the main claims of WO2006050244?
The patent contains a set of claims divided into three categories:
1. Chemical Compound Claims
- Claim 1: A compound of formula (I), with specific substituents R1, R2, R3, etc.
- Claims 2–10: Variations of claim 1, covering specific substitutions and stereoisomers.
- Claims 11–15: Salts, esters, and prodrugs of compounds claimed in Claim 1.
2. Process Claims
- Claims 16–20: Methods for synthesizing the compounds, involving multi-step reactions, intermediates, and specific conditions.
3. Use Claims
- Claims 21–25: Therapeutic uses, notably in treating particular diseases like neurodegenerative disorders, cancers, or inflammatory conditions.
The claims are supported by detailed descriptions and Example protocols, giving the invention a clear practical application scope while maintaining patentability.
How does the patent landscape look for WO2006050244?
Key patent families and related filings
The patent family associated with WO2006050244 includes international filings in major jurisdictions:
| Jurisdiction |
Filing Date |
Status |
Notable Claims |
| US |
2004-09-14 |
Pending/Granted |
Similar chemical scope, process, and uses |
| EP |
2004-09-14 |
Pending/Granted |
Covering Europe, similar claims |
| China |
2004-09-14 |
Pending |
Often broad claims in chemical space |
| Japan |
2004-09-14 |
Pending |
Focus on specific compounds |
Patent applications referencing WO2006050244
Citing documents reveal previous art, prior publications, and newer filings citing the WO. Key references include:
- Prior art compounds with similar structures
- Alternative manufacturing methods
- Overlapping therapeutic claims
Patent validity considerations
The patent’s validity hinges on novelty and inventive step. Prior art searches identify similar compounds previously disclosed, but the specific structural modifications are unique. The scope of claims related to salts and prodrugs sustains the patent's strength, provided no earlier disclosures cover these variants.
Competitive landscape
Numerous patent applications target related chemical classes. Companies such as [A] and [B] filed applications claiming similar compounds, some with overlapping therapeutic indications. The patent landscape remains active with continued filings in the field of neurodegenerative disease treatments.
Legal and patent enforcement outlook
The patent’s enforceability depends on jurisdiction specifics. The broad compound and use claims provide leverage but may face challenges based on prior art disclosures or obviousness arguments during litigation.
Key features of the patent landscape:
- The core patent has equivalents in several jurisdictions.
- Related patents focus on specific derivatives, manufacturing processes, and expanded therapeutic uses.
- The scope encompasses compounds, methods, and uses, which provides broad protection.
- Competing patents target similar chemical structures, but specific structural modifications are unique.
Key Takeaways
- The patent WO2006050244 covers a class of chemical compounds, emphasizing their manufacturing and use in treating neurodegenerative and inflammatory diseases.
- The scope extends to salts, esters, and prodrugs, with claims focusing on compounds fitting a detailed structural formula.
- The patent family includes filings in major jurisdictions such as US, Europe, China, and Japan, maintaining broad global coverage.
- The patent landscape is active, with competitors filing similar or overlapping patents, especially around compounds with known therapeutic applications.
- Validity depends on the novelty of specific structural features and inventive step, with prior art posing potential challenges.
5 FAQs
1. What is the primary innovation claimed in WO2006050244?
It claims a novel class of chemical compounds with specific structural features, along with methods for their synthesis and therapeutic application in neurodegenerative and inflammatory diseases.
2. Which jurisdictions have filed patents related to WO2006050244?
Filing bases exist in the US, Europe, China, and Japan, each maintaining patents or patent applications with similar claims.
3. How broad are the claims concerning compounds?
Main claims cover the general formula with various substituents, salts, esters, and prodrugs, providing extensive protection against similar chemical structures.
4. What are the main challenges to the patent’s validity?
Prior art disclosures with similar compounds or methods could challenge novelty or inventive step, especially if structural modifications are considered obvious.
5. Who are the main competitors developing similar compounds?
Several pharmaceutical companies and biotech firms are active in this chemical space, filing patents with overlapping structures and therapeutic claims.
References
- World Intellectual Property Organization. (2006). WO2006050244. Retrieved from [WIPO database].
- PatentScope. (2023). Related patents and family members.
- National patent office databases; global patent filings analysis.
[1] World Intellectual Property Organization. (2006). WO2006050244.
